Summary:
- The article announces the publication of positive data from a clinical trial evaluating the effectiveness of Idorsia's drug, daridorexant, in treating chronic insomnia and nocturia (frequent nighttime urination) in patients.
- The study found that daridorexant significantly improved sleep onset, sleep maintenance, and time spent awake at night compared to placebo, with a favorable safety profile.
- The positive results support the potential of daridorexant as a new treatment option for patients suffering from chronic insomnia and nocturia, which can have a significant impact on their quality of life.